Nausea and vomiting in advanced cancer: The Cleveland clinic protocol

Journal of Supportive Oncology

Volumn 11, Issue 1, 2013, Pages 8-13

  Gupta, Mona ^a   Davis, Mellar ^a   LeGrand, Susan ^a   Walsh, Declan ^a   Lagman, Ruth ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BOTULINUM TOXIN A; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; ENEMA; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; KETOROLAC; METOCLOPRAMIDE; OCTREOTIDE; OLANZAPINE; ONDANSETRON; OPIATE; PROMETHAZINE; SALCATONIN;

ABDOMINAL PAIN; ADVANCED CANCER; ARTICLE; CLINICAL FEATURE; COLIC; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; HUMAN; HYPERCALCEMIA; INTESTINE OBSTRUCTION; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; STENT; TREATMENT INDICATION; TREATMENT PLANNING; CLINICAL PROTOCOL; DRUG COMBINATION; NAUSEA; NEOPLASM; STANDARD; VOMITING;

ANTIEMETICS; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; HUMANS; NAUSEA; NEOPLASMS; VOMITING;

MLCS; MLOWN;

EID: 84879385369     PISSN: 15446794     EISSN: 1879596X     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Reuben DB, Mor V. Nausea and vomiting in terminal cancer patients. Arch Intern Med. 1986;146(10):2021-2023.
2. Baines M. Nausea and vomiting in the patient with advanced cancer. J Pain Symptom Manage. 1988;3(2):81-85.
3. Davis MP, Walsh D. Treatment of nausea and vomiting in advanced cancer. Support Care Cancer. 200;8(6):444-452.
4. Tang DM, Friedenberg FK. Gastroparesis: approach, diagnostic evaluation, and management. Dis Mon. 2011;57(2):74-101.
5. Horiot JC, Aapro M. Treatment implications for radiation-induced nausea and vomiting in specific patient groups. Eur J Cancer. 2004;40(7):979-987.
6. Bruera E. Autonomic failure in patients with advanced cancer. J Pain Symptom Manage. 1989;4(3):163-166.
7. Lhermitte F, Gray F, Lyon-Caen O, et al. Cancer and intestinal pseudo-obstruction. Ann Intern Med. 1982;96(4):535.
8. Vowels M. Typhlitis: neutropaenic colitis. Australas Radiol. 1988;32(4):477-479.
9. Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol. 2003;98(11):2363-2371.
10. Rigor BM, Sr. Pelvic cancer pain. J Surg Oncol. 2000;75(4):280-300.
11. Yamanaka R, Koga H, Yamamoto Y, et al. Characteristics of patients with brain metastases from lung cancer in a palliative care center. Support Care Cancer. 2011;19(4):467-473.
12. Hird A, Wong J, Zhang L, et al. Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index. Support Care Cancer. 2010;18(3):335-342.
13. Kinghorn S. Palliative care. Nausea and vomiting. Nurs Times. 1997;93(33):57-60.
14. Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med. 2001;15(3): 247-253.
15. Davis NC. Intestinal succussion splash-a valuable clinical sign insufficiently appreciated. Med J Aust. 1964;1:360-361.
16. Skellchock LE, Goltz RW. Umbilical nodule. Metastatic adenocarcinoma (Sister Mary Joseph nodule). Arch Dermatol. 1992;128(4):548-549,551-552.
17. Winne BURCHARD BE. Blumer's shelf tumor with primary carcinoma of the lung. A case report. J Int Coll Surg. 1965;44(5):477-481.
18. Gu Y, Lim HJ, Moser MA. How useful are bowel sounds in assessing the abdomen? Dig Surg. 2010;27(5):422-426.
19. Rath S, Das BS, Kar C, et al. Intracranial space occupying lesions presenting without papilloedema-a retrospective analysis. Neurol India. 1978;26(3):140-143.
20. Suhardjono. Hyponatremia, prevalence, diagnosis, and management. Acta Med Indones. 2011;43(3):149-151.
21. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer. 2007;15(12):1341-1347.
22. McDonald GA, Dubose TD Jr. Hyponatremia in the cancer patient. Oncology (Williston Park). 1993;7(9):55-64; discussion 67-68; 70-71.
23. Starreveld JS, Pols MA, Van Wijk HJ, et al. The plain abdominal radiograph in the assessment of constipation. Z Gastroenterol. 1990;28(7):335-338.
24. Chou CK, Liu GC, Chen LT, et al. The use of MRI in bowel obstruction. Abdom Imaging. 1993;18(2):131-135.
25. Stewart J, Finan PJ, Courtney DF, et al. Does a water soluble contrast enema assist in the management of acute large bowel obstruction: a prospective study of 117 cases. Br J Surg. 1984;71(10):799-801.
26. Davis MP, Hallerberg G; Palliative Medicine Study Group of the Multinational Association of Supportive Care in Cancer. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage. 2010;39(4):756-767.
27. Davis MP. The opioid bowel syndrome: a review of pathophysiology and treatment. J Opioid Manag. 2005;1(3):153-161.
28. Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2006;14(4):348-353.
29. LeGrand SB, Walsh D. Scopolamine for cancer-related nausea and vomiting. J Pain Symptom Manage. 2010;40(1):136-141.
30. Strohscheer I, Borasio GD. Carbamazepine-responsive paroxysmal nausea and vomiting in a patient with meningeal carcinomatosis. Palliat Med. 2006;20(5):549-550.
31. Ajori L, Nazari L, Mazloomfard MM, et al. Effects of gabapentin on postoperative pain, nausea and vomiting after abdominal hysterectomy: a double blind randomized clinical trial. Arch Gynecol Obstet. 2012;285(3):677-682.
32. Cruz FM, de Iracema Gomes Cubero D, Taranto P, et al. Gabapentin for the prevention of chemotherapy-induced nausea and vomiting: a pilot study. Support Care Cancer. 2012;20(3):601-606.
33. Khademi S, Ghaffarpasand F, Heiran HR, et al. Effects of preoperative gabapentin on postoperative nausea and vomiting after open cholecystectomy: a prospective randomized double-blind placebocontrolled study. Med Princ Pract. 2010;19(1):57-60.
34. Mohammadi SS, Seyedi M. Effects of gabapentin on early postoperative pain, nausea and vomiting in laparoscopic surgery for assisted reproductive technologies. Pak J Biol Sci. 2008;11(14):1878-1880.
35. Ho KY. Gabapentin for postoperative nausea and vomiting prophylaxis. J Postgrad Med. 2006;52(3):230; author reply 30-31.
36. Soriano A, Davis MP. Malignant bowel obstruction: individualized treatment near the end of life. Cleve Clin J Med. 2011;78(3):197-206.
37. Joishy SK, Walsh D. The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome. J Pain Symptom Manage. 1998;16(5):334-339.
38. Bicanovsky LK, Lagman RL, Davis MP, et al. Managing nonmalignant chronic abdominal pain and malignant bowel obstruction. Gastroenterol Clin North Am. 2006;35(1):131-142.
39. Davis MP, Furste A. Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction. J Pain Symptom Manage. 1999;18(3):153-154.
40. McCallum P, Walsh D, Nelson KA. Can a soft diet prevent bowel obstruction in advanced pancreatic cancer? Support Care Cancer. 2002;10(2):174-175.
41. Mercadante S. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction. J Pain Symptom Manage. 1998;16(5): 278-280.
42. Mercadante S, Porzio G. Octreotide for malignant bowel obstruction: Twenty years after. Crit Rev Oncol Hematol. 2012;83(3);388-392.
43. Elsayem A, Bush SH, Munsell MF, et al. Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study. J Pain Symptom Manage. 2010;40(5):774-782.
44. Gonzalez-Rosales F, Walsh D. Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). J Pain Symptom Manage. 1997;14(5):311-314.
45. Brücher BL, Stein HJ, Bartels H, et al. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg. 2001;25(6):745-749.